66 results
DEFA14A
NRIX
Nurix Therapeutics Inc
25 Mar 22
Additional proxy soliciting materials
7:06am
Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
NURIX THERAPEUTICS, INC.
(Name of Registrant as Specified in Its … required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1
DRS
EX-10.10
NRIX
Nurix Therapeutics Inc
5 May 20
Draft registration statement
12:00am
Responsibility
Development Diligence
Development Updates
ARTICLE 5
REGULATORY
Regulatory Matters
Regulatory Materials
Right of Reference; Access … materials, chemical structures, Commercialization plans, correspondence, customer lists, Research plans, Development plans, Know-How, regulatory
S-1
EX-10.10
thfor
2 Jul 20
IPO registration
4:04pm
DRS/A
EX-10.8
a6s58va
10 Jun 20
Draft registration statement (amended)
12:00am
DRS
EX-10.9
4la9plqqi qh
5 May 20
Draft registration statement
12:00am
DEF 14A
m2mr0v5 9piruhm
25 Mar 21
Definitive proxy
6:03am
S-1
EX-10.8
5armsk13f7cscb5 qyv
2 Jul 20
IPO registration
4:04pm
DEFA14A
0eezkf2sy6
25 Mar 21
Additional proxy soliciting materials
6:08am
S-1
EX-10.9
z5n7t
2 Jul 20
IPO registration
4:04pm
DEFA14A
i0avnq9
27 Mar 24
Additional proxy soliciting materials
7:02am
DRSLTR
3oyuksn5
10 Jun 20
Correspondence regarding draft registration statement
12:00am
D
1pc1ennwwx1p9qlt
2 Jan 14
$25.15M in equity, sold $2.08M, 2 investors
12:00am